Stratton Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$9.51M Sell
112,849
-5,000
-4% -$415K 1.15% 20
2015
Q3
$9.86M Buy
117,849
+13,725
+13% +$1.16M 1.13% 22
2015
Q2
$8.69M Sell
104,124
-8,975
-8% -$684K 0.38% 86
2015
Q1
$8.22M Buy
113,099
+5,500
+5% +$392K 0.33% 100
2014
Q4
$7.42M Buy
107,599
+1,575
+1% +$106K 0.31% 110
2014
Q3
$6.88M Sell
106,024
-1,900
-2% -$120K 0.31% 103
2014
Q2
$6.71M Sell
107,924
-500
-0.5% -$29.8K 0.28% 117
2014
Q1
$6.38M Buy
108,424
+175
+0.2% +$9.77K 0.29% 108
2013
Q4
$5.52M Sell
108,249
-525
-0.5% -$26.3K 0.26% 120
2013
Q3
$5.47M Buy
108,774
+850
+0.8% +$44.5K 0.28% 115
2013
Q2
$5.3M Buy
+107,924
New +$5.87M 0.31% 111

Other funds holding LLY

Stratton Management's LLY Position: Q4 2015 in Review

Stratton Management reduced its Eli Lilly (LLY) stake by 4.2% in Q4 2015, selling an estimated $415K and leaving 112,849 shares worth $9.51M. The position accounts for 1.15% of the portfolio, ranked #20.

Stratton Management first reported a position in LLY in Q2 2013 and has held it in 11 quarters since. The position peaked at $9.86M in Q3 2015. 1,221 funds tracked by Wall St. Rank hold LLY as of Q4 2015.

  • Stratton Management held 112,849 shares of Eli Lilly worth $9.51M as of Q4 2015.
  • Stratton Management sold 5,000 Eli Lilly shares in Q4 2015, an estimated $415K.
  • Eli Lilly made up 1.15% of Stratton Management's portfolio in Q4 2015, its #20 holding.
  • Stratton Management first reported a position in Eli Lilly in Q2 2013 and has held it in 11 quarters since.
  • Stratton Management's Eli Lilly position peaked at $9.86M in Q3 2015.
  • 1,221 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.